Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Scholar Rock , a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein ...

F45 Training Holdings Inc., a leading global fitness community known for innovative, high-energy group workouts, announced ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

New analysis from GlobalData spans the growth of the heart failure market across seven major markets including the US, Europe ...

Viking Therapeutics VKTX announced that it has started the phase II VENTURE-Oral Dosing study to evaluate the safety and ...

Browse in-depth TOC on " Global Biotechnology industry Outlook " 10 - Tables 20 - Figures 70 - Pages . The Global Biotech ...

Industry leaders share their thoughts and concerns about the health care landscape and how it will affect their 2025.